Modern Chinese Medicine Group Co (HKSE:01643) EBITDA Margin % : -5.65% (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Modern Chinese Medicine Group Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Modern Chinese Medicine Group Co's EBITDA for the six months ended in Jun. 2024 was HK$-4.7 Mil. Modern Chinese Medicine Group Co's Revenue for the six months ended in Jun. 2024 was HK$82.5 Mil. Therefore, Modern Chinese Medicine Group Co's EBITDA margin for the quarter that ended in Jun. 2024 was -5.65%.

Modern Chinese Medicine Group Co EBITDA Margin % Historical Data

The historical data trend for Modern Chinese Medicine Group Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modern Chinese Medicine Group Co EBITDA Margin % Chart

Modern Chinese Medicine Group Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBITDA Margin %

Get a 7-Day Free Trial

29.98

32.44

32.54

21.73

6.92

Modern Chinese Medicine Group Co Semi-Annual Data
	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EBITDA Margin %	Get a 7-Day Free Trial								27.89	21.80	17.72	-5.65	13.93

Competitive Comparison of Modern Chinese Medicine Group Co's EBITDA Margin %

For the Drug Manufacturers - General subindustry, Modern Chinese Medicine Group Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Modern Chinese Medicine Group Co's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Modern Chinese Medicine Group Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Modern Chinese Medicine Group Co's EBITDA Margin % falls into.

Save Embed

;

Save Embed

;

Modern Chinese Medicine Group Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Modern Chinese Medicine Group Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	81.761	/	376.342
	=	21.73 %

Modern Chinese Medicine Group Co's EBITDA Margin % for the quarter that ended in Jun. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	-4.659	/	82.489
	=	-5.65 %

Modern Chinese Medicine Group Co (HKSE:01643) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Modern Chinese Medicine Group Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Modern Chinese Medicine Group Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Modern Chinese Medicine Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Modern Chinese Medicine Group Co Ltd (HKSE:01643) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 88 Jinwei Road, Hebei, Chengde, CHN, 068150

Website

http://www.cdysjdyy.com

Modern Chinese Medicine Group Co Ltd is engaged in the production of Proprietary Chinese Medicines. It offers both OTC and prescribed medicines intended for use by the Middle-aged and the Elderly in the PRC. Its products include liver protection tablets, Shanmei capsules, Qi and blood supplement pills, and Xiaohuoluo pills among others. Geographically, the company derives its key revenue from the People's Republic of China.

Executives

Sun Xinlei	2201 Interest of corporation controlled by you
Xian Dai Sheng Wu Ke Ji Ji Tuan Kong Gu You Xian Gong Si	2101 Beneficial owner
Xie Wei	2201 Interest of corporation controlled by you

Modern Chinese Medicine Group Co Headlines

No Headlines